The latest announcement is out from WW International, Inc. (WW).
WW International, Inc. has announced to its employees that it expects to surpass its first-quarter fiscal 2024 end-of-period Clinical subscriber targets, exceeding initial forecasts. This positive outlook is based on current management predictions, though it comes with a caution that actual results may vary due to certain risk factors, as detailed in their recent SEC filing. The company emphasizes that this information is preliminary and may not be used for legal purposes or considered as filed under securities law.
For detailed information about WW stock, go to TipRanks’ Stock Analysis page.
